Pope Leo Diagnosed with Lung Cancer
Digest more
Oct 12 (Reuters) - Bristol Myers Squibb said on Monday a lower dose of its experimental drug met the main goal of a ...
After surgery on Tuesday to remove the lower lobe of his right lung, Pope Leo, 71, was diagnosed with lung adenocarcinoma.
Bristol Myers reported that its late-stage ALOFT-IPF trial of the oral drug admilparant met the primary endpoint at the 60 mg twice-daily dose in patients with Idiopathic Pulmonary Fibrosis.
Lung function was reduced with higher glucose, lower insulin sensitivity and impaired insulin clearance in adults without ...
Randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy in a robust, two-part studyFirst-in-class therapeutic ...
A French pilot study shows automated quantitative CT analysis can objectively measure lung damage in pulmonary Langerhans ...
Four years after Ultra Low Emission Zone implementation in London, lung function growth trajectories of school-aged children improved and nitrogen dioxide exposure fell, according to data published in ...
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial. The results of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results